A Repeated Amphetamine Model of Impaired Attention in Schizophrenia.

作者: Vicente Martinez

DOI:

关键词:

摘要: Cognitive impairments, including deficits in attention processing, represent major and central elements of schizophrenic symptoms. Firstand secondgeneration antipsychotic drugs can effectively mitigate the florid symptoms psychosis. However, treating schizophrenia’s cognitive remains problematic has met with limited success. Evidence indicates that basal forebrain cholinergic system (BFCS) is an essential component neuronal circuitry involved mediating processing processingan important aspect cognition. The present thesis based on core hypothesis dysregulation contributes to impairments associated Using a repeated-amphetamine (AMPH) rat model schizophrenia, following main hypotheses are tested: 1) Repeated, escalating AMPH administration, followed by ‘AMPHchallenges’ at previously innocuous doses, results performance task measures sustained attention. 2) consequences repeated-AMPH administration subsequent challenge dosing task-performing animals include dysregulated cortical transmission. 3) In AMPH-pretreated performing task; sub-chronic, low-dose will attenuate impairments. findings provide evidence for aberrant regulation impaired schizophrenia. Specifically, pretreatment resulted markedly attenuated

参考文章(237)
N. Müller, Mechanisms of relapse prevention in schizophrenia. Pharmacopsychiatry. ,vol. 37, pp. 141- 147 ,(2004) , 10.1055/S-2004-832668
ERIK B. NIELSEN, MELVIN LYON, GAYLORD ELLISON, Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis. Journal of Nervous and Mental Disease. ,vol. 171, pp. 222- 233 ,(1983) , 10.1097/00005053-198304000-00004
J.S. Andrews, S.G. Holtzman, Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats Psychopharmacology. ,vol. 94, pp. 172- 177 ,(1988) , 10.1007/BF00176840
AnthonyG. Greenwald, Richard Gonzalez, Richard.J. Harris, Donald Guthrie, Effect sizes and p values: What should be reported and what should be replicated? Psychophysiology. ,vol. 33, pp. 175- 183 ,(1996) , 10.1111/J.1469-8986.1996.TB02121.X
Cecilia Flores, Xianglan Wen, Cassandre Labelle-Dumais, Bryan Kolb, Chronic phencyclidine treatment increases dendritic spine density in prefrontal cortex and nucleus accumbens neurons. Synapse. ,vol. 61, pp. 978- 984 ,(2007) , 10.1002/SYN.20452
Terry E. Robinson, Bryan Kolb, Structural plasticity associated with exposure to drugs of abuse Neuropharmacology. ,vol. 47, pp. 33- 46 ,(2004) , 10.1016/J.NEUROPHARM.2004.06.025
Richard S E Keefe, Robert M Bilder, Philip D Harvey, Sonia M Davis, Barton W Palmer, James M Gold, Herbert Y Meltzer, Michael F Green, Del D Miller, Jose M Canive, Lawrence W Adler, Theo C Manschreck, Marvin Swartz, Robert Rosenheck, Diana O Perkins, Trina M Walker, T Scott Stroup, Joseph P McEvoy, Jeffrey A Lieberman, Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial Neuropsychopharmacology. ,vol. 31, pp. 2033- 2046 ,(2006) , 10.1038/SJ.NPP.1301072
Barbara K Lipska, Daniel R Weinberger, To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test Neuropsychopharmacology. ,vol. 23, pp. 223- 239 ,(2000) , 10.1016/S0893-133X(00)00137-8
Stacy A Castner, Mohammed S Al-Tikriti, Ronald M Baldwin, John P Seibyl, Robert B Innis, Patricia S Goldman-Rakic, Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine. Neuropsychopharmacology. ,vol. 22, pp. 4- 13 ,(2000) , 10.1016/S0893-133X(99)00080-9